AMED Co (ROCO:7575) Debt-to-Equity : 0.60 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is AMED Co Debt-to-Equity?

AMED Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$112.0 Mil. AMED Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$145.4 Mil. AMED Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was NT$426.0 Mil. AMED Co's debt to equity for the quarter that ended in Dec. 2023 was 0.60.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for AMED Co's Debt-to-Equity or its related term are showing as below:

ROCO:7575' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.6 Med: 1.18 Max: 1.61
Current: 0.6

During the past 5 years, the highest Debt-to-Equity Ratio of AMED Co was 1.61. The lowest was 0.60. And the median was 1.18.

ROCO:7575's Debt-to-Equity is ranked worse than
76.98% of 708 companies
in the Medical Devices & Instruments industry
Industry Median: 0.215 vs ROCO:7575: 0.60

AMED Co Debt-to-Equity Historical Data

The historical data trend for AMED Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AMED Co Debt-to-Equity Chart

AMED Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

1.61

1.28

1.18

0.87

0.60

AMED Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial				1.18	1.12	0.87	0.74	0.60

Competitive Comparison of AMED Co's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, AMED Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AMED Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AMED Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where AMED Co's Debt-to-Equity falls into.

AMED Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

AMED Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(111.975	+	145.416)	/	426.039
	=	0.60

AMED Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(111.975	+	145.416)	/	426.039
	=	0.60

AMED Co (ROCO:7575) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

AMED Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of AMED Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AMED Co (ROCO:7575) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AMED Co Ltd (ROCO:7575) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 14, Wuquan 7th Road, 4th Floor, Wugu District, New Taipei, TWN

Website

https://www.amed.com.tw

AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.

AMED Co (ROCO:7575) Headlines

No Headlines